TG Therapeutics | TGTX - Assets

Stock Price
30.48
Daily Change
0.82 2.76%
Monthly
-1.04%
Yearly
6.83%
Q1 Forecast
28.61

TG Therapeutics reported $1.06B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Amgen USD 90.59B 445M Dec/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.44B 232M Dec/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Curis USD 29.23M 10.09M Jun/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
J&J USD 199.21B 6.39B Dec/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novavax USD 1.18B 156.66M Sep/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Puma Biotechnology USD 202.86M 7.95M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.06B 38.23M Dec/2025
Verastem USD 131.7M 30.16M Mar/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025